Novel Pharmacology Following Heteromerization of the Angiotensin II Type 2 Receptor and the Bradykinin Type 2 Receptor.

Autor: Johnstone EKM; Harry Perkins Institute of Medical Research and Centre for Medical Research, The University of Western Australia, Nedlands, WA, Australia.; Australian Research Council Centre for Personalised Therapeutics Technologies, Perth, WA, Australia.; School of Biomedical Sciences, The University of Western Australia, Nedlands, WA, Australia., Ayoub MA; Harry Perkins Institute of Medical Research and Centre for Medical Research, The University of Western Australia, Nedlands, WA, Australia.; Department of Biology, College of Science, United Arab Emirates University, Al Ain, United Arab Emirates., Hertzman RJ; Harry Perkins Institute of Medical Research and Centre for Medical Research, The University of Western Australia, Nedlands, WA, Australia.; School of Biomedical Sciences, The University of Western Australia, Nedlands, WA, Australia., See HB; Harry Perkins Institute of Medical Research and Centre for Medical Research, The University of Western Australia, Nedlands, WA, Australia.; Australian Research Council Centre for Personalised Therapeutics Technologies, Perth, WA, Australia., Abhayawardana RS; Harry Perkins Institute of Medical Research and Centre for Medical Research, The University of Western Australia, Nedlands, WA, Australia.; Australian Research Council Centre for Personalised Therapeutics Technologies, Perth, WA, Australia., Seeber RM; Harry Perkins Institute of Medical Research and Centre for Medical Research, The University of Western Australia, Nedlands, WA, Australia.; Australian Research Council Centre for Personalised Therapeutics Technologies, Perth, WA, Australia., Pfleger KDG; Harry Perkins Institute of Medical Research and Centre for Medical Research, The University of Western Australia, Nedlands, WA, Australia.; Australian Research Council Centre for Personalised Therapeutics Technologies, Perth, WA, Australia.; Dimerix Limited, Nedlands, WA, Australia.

Publikováno v: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2022 May 26; Vol. 13, pp. 848816. Date of Electronic Publication: 2022 May 26 (Print Publication: 2022).

Immunopharmacogenomics: Mechanisms of HLA-Associated Drug Reactions.

Autor: Deshpande P; Institute for Immunology and Infectious Diseases (IIID), Murdoch University, Western Australia, Australia., Hertzman RJ; Institute for Immunology and Infectious Diseases (IIID), Murdoch University, Western Australia, Australia., Palubinsky AM; Department of Medicine, Vanderbilt University Medical Centre, Nashville, Tennessee, USA., Giles JB; Department of Pharmacy Practice & Science, University of Arizona, Tucson, Arizona, USA., Karnes JH; Department of Medicine, Vanderbilt University Medical Centre, Nashville, Tennessee, USA.; Department of Pharmacy Practice & Science, University of Arizona, Tucson, Arizona, USA., Gibson A; Institute for Immunology and Infectious Diseases (IIID), Murdoch University, Western Australia, Australia., Phillips EJ; Institute for Immunology and Infectious Diseases (IIID), Murdoch University, Western Australia, Australia.; Department of Medicine, Vanderbilt University Medical Centre, Nashville, Tennessee, USA.

Publikováno v: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2021 Sep; Vol. 110 (3), pp. 607-615. Date of Electronic Publication: 2021 Jul 17.

Visual Genomics Analysis Studio as a Tool to Analyze Multiomic Data.

Autor: Hertzman RJ; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, WA, Australia., Deshpande P; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, WA, Australia., Leary S; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, WA, Australia., Li Y; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, WA, Australia., Ram R; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, WA, Australia., Chopra A; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, WA, Australia.; Department of Medicine, Vanderbilt University Medical Centre, Nashville, TN, United States., Cooper D; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, WA, Australia., Watson M; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, WA, Australia., Palubinsky AM; Department of Medicine, Vanderbilt University Medical Centre, Nashville, TN, United States., Mallal S; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, WA, Australia.; Department of Medicine, Vanderbilt University Medical Centre, Nashville, TN, United States., Gibson A; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, WA, Australia., Phillips EJ; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, WA, Australia.; Department of Medicine, Vanderbilt University Medical Centre, Nashville, TN, United States.

Publikováno v: Frontiers in genetics [Front Genet] 2021 Jun 17; Vol. 12, pp. 642012. Date of Electronic Publication: 2021 Jun 17 (Print Publication: 2021).